1009 related articles for article (PubMed ID: 33284535)
1. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract][Full Text] [Related]
2. Prognostic nomogram for patients with lung metastatic renal cell carcinoma: a SEER-based study.
Mao W; Fu Z; Wang K; Wu J; Xu B; Chen M
Ann Palliat Med; 2021 Mar; 10(3):2791-2804. PubMed ID: 33549017
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma.
Zheng W; Zhu W; Yu S; Li K; Ding Y; Wu Q; Tang Q; Zhao Q; Lu C; Guo C
BMC Cancer; 2020 Nov; 20(1):1066. PubMed ID: 33148204
[TBL] [Abstract][Full Text] [Related]
4. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
6. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of prognostic nomogram for lung cancer patients below the age of 45 years.
Dai L; Wang W; Liu Q; Xia T; Wang Q; Chen Q; Zhu N; Cheng Y; Yan Y; Shu J; Qu K
Bosn J Basic Med Sci; 2021 Jun; 21(3):352-363. PubMed ID: 33091332
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors and a Nomogram Predicting Overall Survival and Cancer-Specific Survival for Patients with Collecting Duct Renal Cell Carcinoma.
Xiao R; Liu C; He W; Ma L
Biomed Res Int; 2021; 2021():6736008. PubMed ID: 34805402
[TBL] [Abstract][Full Text] [Related]
9. Nomogram to predict risk and prognosis of synchronous lung metastasis in renal cell carcinoma: A large cohort analysis.
Lu Z; Yang C; He W; Zhou J; Xiang R
Medicine (Baltimore); 2022 Jul; 101(27):e29764. PubMed ID: 35801802
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of nomograms for predicting overall survival and cancer specific survival in locally advanced breast cancer patients: A SEER population-based study.
Yin F; Wang S; Hou C; Zhang Y; Yang Z; Wang X
Front Public Health; 2022; 10():969030. PubMed ID: 36203704
[TBL] [Abstract][Full Text] [Related]
11. Specific survival nomograms based on SEER database for small intestine adenocarcinoma.
Wang D; Li C; Li Y; Liu W; Zhao L; Güngör C; Tan F; Zhou Y
Ann Palliat Med; 2021 Jul; 10(7):7440-7457. PubMed ID: 34263641
[TBL] [Abstract][Full Text] [Related]
12. Establishment and validation of systematic prognostic nomograms in patients over 60 years of age with osteosarcoma: A multicenter external verification study.
Shao Z; Li J; Liu Z; Bi S
Cancer Med; 2023 Apr; 12(8):9589-9603. PubMed ID: 36992547
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a nomogram to predict long-term cancer-specific survival for patients with osteosarcoma.
Yu Y; Wang S; Liu J; Ge J; Guan H
Sci Rep; 2023 Jun; 13(1):10230. PubMed ID: 37353555
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
15. Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.
Wang H; Chen X; Zhao J; Kang M; Dong R; Wang K; Qu Y
Med Sci Monit; 2020 Jun; 26():e921859. PubMed ID: 32570266
[TBL] [Abstract][Full Text] [Related]
16. Nomogram predicts the prognosis of patients with thymic carcinoma: A population-based study using SEER data.
Huang YY; Liu X; Liang SH; Wu LL; Ma GW
Tumori; 2023 Jun; 109(3):282-294. PubMed ID: 35897150
[TBL] [Abstract][Full Text] [Related]
17. A novel nomogram and risk classification system predicting the overall survival of patients with papillary renal cell carcinoma after nephrectomy: A population-based study.
Hu Y; Xu S; Qi Q; Wang X; Meng J; Zhou J; Hao Z; Liang Q; Feng X; Liang C
Front Public Health; 2022; 10():989566. PubMed ID: 36276376
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.
Ma Q; Chen Z; Fang Y; Wei X; Wang N; Zhou X; Li S; Ying C
J Endocrinol Invest; 2024 Jan; 47(1):115-129. PubMed ID: 37294407
[TBL] [Abstract][Full Text] [Related]
19. The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database.
Yu G; Liu X; Li Y; Zhang Y; Yan R; Zhu L; Wang Z
Front Public Health; 2022; 10():946299. PubMed ID: 36159305
[TBL] [Abstract][Full Text] [Related]
20. Construction and validation of a novel prognostic nomogram for patients with metastatic renal cell carcinoma: a SEER-based study.
Lu Z; He W; Zhou J; Yang C; Xiang R
J Int Med Res; 2022 Jun; 50(6):3000605221105367. PubMed ID: 35726570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
